PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.\', \'Feinstein Institutes for Medical Research, Northwell Health, Manhasset, USA.\', \'North Shore University Hospital, Northwell Health, Manhasset, USA.\', \'Department of Information Services, Northwell Health, New Hyde Park, USA.\', \'Division of Cardiology, Lenox Hill Hospital, Northwell Health, New York, USA.\', \'Department of Medicine, Northwell Health, Manhasset, USA.\', \'CommonSpirit Health, Baylor College of Medicine, Houston, TX, USA.\', \'Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA. aspyropoul@northwell.edu.\', \'Feinstein Institutes for Medical Research, Northwell Health, Manhasset, USA. aspyropoul@northwell.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11239-021-02504-5
?:hasPublicationType
?:journal
  • Journal of thrombosis and thrombolysis
is ?:pmid of
?:pmid
?:pmid
  • 34146235
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.991
?:rankingScore_hIndex
  • 57
?:title
  • External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all